Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Expenses

9 Months Ended

Sep. 30, 2023

10. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:


	September 30,			December 31,
($ in thousands)	2023		2022

Accounts payable	$	44,731	$	57,244
Accrued expenses:
Professional fees		2,295		1,693
Salaries, bonus and related benefits		8,585		9,772
Research and development		7,446		7,390
Research and development - license maintenance fees		4,456		632
Research and development - milestones		—		4,600
Accrued royalties payable		1,794		2,627
Accrued coupon and rebates		6,099		7,604
Return reserve		4,523		3,689
Accrued interest		16		342
Other		1,461		1,853
Total accounts payable and accrued expenses	$	81,406	$	97,446